Sweden· SE-20140111000101
Curosurf 80 mg/ml Instillationsvätska för luftvägarna, suspension
A medicinal product containing poractant alfa, registered in Sweden by Orifarm AB.
Checked against Swedish Medical Products Agency (Sweden) on
Informational only — not a medical device.
The record
At a glance
Swedish Medical Products Agency (Sweden)- Active substance
- Poractant Alfa
- Manufacturer
- Orifarm AB
- Country
- Sweden (SE)
- ATC code
- —
- Reimbursed
- Not published by this register
- Source register
- Swedish Medical Products Agency (Sweden)
- Last checked
- October 1, 2026
Packs & prices · 1
- se_varunummer20140111000101
Regulatory notes
No shortage, Orange Book or US label notes for this record.
Same medicine, other countries
Poractant alfa in 9 other countries
What each register calls a product with the same active substance — salts and hydrates count as the same.
- PolandCurosurfDelfarma Sp. z o.o.
- NorwayCurosurfChiesi Farmaceutici S.p.a.
- FinlandCurosurfChiesi Farmaceutici S.p.A.
- FranceCUROSURF 120 mg/1,5 ml, suspension pour instillation endotrachéobronchiqueCHIESI
- United KingdomCurosurf 120mg/1.5ml endotracheopulmonary suspension vialsChiesi Ltd
- IrelandCUROSURF 120 mg/vial Endotracheopulmonary instillation, suspensionChiesi Farmaceutici S.p.A.
- United StatesCurosurfChiesi USA, Inc.
- GermanyCurosurfChiesi Gmbh
Authorised across Europe · EMA
The same active substance is authorised in 28 EEA countries. Names it is sold under:
- Austria · Curosurf
- Belgium · Curosurf
- Bulgaria · Куросърф
- Cyprus · Curosurf
- Czechia · Curosurf
- Denmark · Curosurf
- Estonia · Curosurf
- Spain · Curosurf
- Finland · Curosurf
- France · Curosurf
- United Kingdom (Northern Ireland) · Curosurf
- Greece · Curosurf
- Croatia · Curosurf
- Hungary · Curosurf
- Ireland · Curosurf
- Iceland · Curosurf
- Italy · Curosurf
- Lithuania · Curosurf
- Luxembourg · Curosurf
- Latvia · Curosurf
- Malta · Curosurf
- Netherlands · Curosurf
- Norway · Curosurf
- Poland · Curosurf
- Portugal · Curosurf
- Romania · Curosurf
- Slovenia · Curosurf
- Slovakia · Curosurf
Source: European Medicines Agency, Article 57 product data.
Sourced from a public register and reproduced with attribution. Drug Database is not affiliated with, endorsed by, or a partner of Swedish Medical Products Agency (Sweden). This is an informational data service and not a medical device — verify against the official source of record before any clinical decision.
For developers
The same record over the API, and the raw payload
GET /v1/drugs/7f539486-fe4d-45b7-983f-4b5db1900683 GET /v1/drugs/7f539486-fe4d-45b7-983f-4b5db1900683?format=fhir
Every response carries last_synced_at, so freshness is a field rather than a promise. Below is exactly what the ingestion wrote, before any presentation — the same JSON the API returns under payload.
{
"source": "lakemedelsverket",
"doc_types": [
"PL"
],
"se_npl_id": "20140111000101",
"product_page": "https://www.lakemedelsverket.se/sv/sok-lakemedelsfakta/lakemedel?id=20140111000101",
"product_doc_link": "https://docetp.mpa.se/LMF/Curosurf%2080%20mg%20per%20ml%20endotracheopulmonary%20instillation%2C%20suspension%20BG%20PL_09001bee807a401e.pdf"
}See everything about poractant alfa.
This page is the registration. A free account adds the label text as the regulator wrote it, what it costs per daily dose across the markets that publish a price, a feed of what changes in the registers, and an assistant that answers with its sources. Interaction severity is free; mechanism and management are on the Growth plan. No card, nothing to install.